Heart Failure and Cardiomyopathies
Contemporary management of heart failure requires a team approach to achieve the best outcomes for this complex patient population, and the Heart Failure and Cardiomyopathies Pathway exemplifies a multidisciplinary approach in substance and action.
The Heart Failure Team consists of nurses, pharmacists, social workers, nutritionists, geneticists, cardiologists across the various subspecialties (heart failure, interventional, electrophysiology), and cardiothoracic surgeons. And many sessions in this pathway include representatives from a broad range of disciplines and career stages — from the best and brightest early career to the most senior experts in the field, and the best scientists in cardiovascular research to help translate the latest scientific findings into improving care of heart failure patients.
The program includes many new and hot topics as well as debates and panel discussions related to the broad array of complexities and comorbidities that all cardiovascular professionals face in patient care today. In addition, as treatment options improve for cancer patients, cancer and heart failure topics take on increasing importance and will be covered in several sessions. Other sessions focus on the aspects of treating patients with heart failure in a time of so much transition in the business aspects of medicine.
Attendees will find the Heart Failure and Cardiomyopathies Learning Pathway takes a more inclusive approach to improving treatment options for patients with heart failure.
- Highlighted Original Research: Heart Failure and Cardiomyopathies and the Year in Review (Session #901)
- Joint Symposium of the American Heart Association and the American College of Cardiology: Regenerative Therapy in Cardiovascular Disease (Session #709)
- Emerging Therapies in Heart Failure: The Crystal Ball (Session #639)
- Sweetening the Pill: New Options for Treating Diabetes in Heart Failure (Session #750)
- Cardiogenic Shock and Acute Mechanical Support Strategies (Session #653)
- Genetic Testing for Cardiomyopathies (Session #610)
- Heart Failure in Cancer Survivors: Cured of Cancer but Now Let's Heal the Heart (Session #722)
- Unanswered Questions in Cancer and Heart Failure (Session #749)
- Putting Key Guideline Recommendations into Day-to-Day Practice: A Case Based Approach from the Masters (Session #694)
- Impact of Evolving Health Care Reforms on Heart Failure Patients (Session #667)
- Multiple Faces of HFpEF: Learning with the Experts (Session #681)
- Planning Ahead: Palliative Care in End-Stage Heart Failure (Session #626)
- International Clinical Trials in Heart Failure: Beyond Cultural Barriers: Heart Failure Society of America and ACC Joint Symposium (Session #666)
- HELLP! My Patient With Heart Disease Is Now Pregnant (Session # 603)
- Hypertrophic Cardiomyopathy as a Contemporary Treatable Disease (session #625)
| 2018 American College of Cardiology Foundation. Visit ACC.org|